Updates on cardiovascular outcome trials in diabetes

Updates on cardiovascular outcome trials in diabetes

Abstract In 2008 the Food and Drug Administration introduced a guidance for industry that requires the investigation of cardiovascular outcomes of glucose-lowering medications. Since then, an increasing number of cardiovascular outcome trials have been completed in diabetes patients with high cardio...

Full description

Bibliographic Details
Main Authors: Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular risk
Diabetes
CVOT
DEVOTE
CANVAS program
EXSCEL
Online Access:http://link.springer.com/article/10.1186/s12933-017-0610-y

Internet

http://link.springer.com/article/10.1186/s12933-017-0610-y

Similar Items